Literature DB >> 20010219

In populo.

Daniel Westreich1, Brian W Pence, Abigail Norris Turner.   

Abstract

While the Latin phrases in vitro and in vivo are well understood in the medical literature, neither term accurately describes the science performed at the level of the population by epidemiologists and others. In particular, the effect of an exposure in a single organism can differ from those in a population, for reasons ranging from random error to herd immunity. We suggest that in populo (meaning literally "in the people") can fill this gap in the literature.

Entities:  

Mesh:

Year:  2010        PMID: 20010219      PMCID: PMC2882154          DOI: 10.1097/EDE.0b013e3181c1e92a

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  11 in total

1.  AIDSVAX (MN) in Bangkok injecting drug users: a report on safety and immunogenicity, including macrophage-tropic virus neutralization.

Authors:  S Migasena; P Suntharasamai; P Pitisuttithum; D Kitayaporn; C Wasi; W Huang; S Vanichseni; C Koompong; J Kaewkungwal; S Raktham; T Ippolito; C Hanson; T Gregory; W L Heyward; P Berman; D Francis
Journal:  AIDS Res Hum Retroviruses       Date:  2000-05-01       Impact factor: 2.205

Review 2.  Herd immunity and herd effect: new insights and definitions.

Authors:  T J John; R Samuel
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

3.  FUNCTION OF THE EX-VIVO PIG LIVER PERFUSED WITH HUMAN BLOOD.

Authors:  D S LIEM; T L WALTUCH; B EISEMAN
Journal:  Surg Forum       Date:  1964

4.  TISSUE GROWTH IN VITRO.

Authors: 
Journal:  Cal State J Med       Date:  1911-09

5.  PRELIMINARY REPORT OF A METHOD FOR ESTIMATING IN VIVO THE GERMICIDAL ACTIVITY OF ANTISEPTICS.

Authors:  J A Perkins
Journal:  Ann Surg       Date:  1918-09       Impact factor: 12.969

6.  Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

Authors:  Neil M Flynn; Donald N Forthal; Clayton D Harro; Franklyn N Judson; Kenneth H Mayer; Michael F Para
Journal:  J Infect Dis       Date:  2005-01-27       Impact factor: 5.226

7.  Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.

Authors:  Punnee Pitisuttithum; Peter Gilbert; Marc Gurwith; William Heyward; Michael Martin; Fritz van Griensven; Dale Hu; Jordan W Tappero; Kachit Choopanya
Journal:  J Infect Dis       Date:  2006-11-03       Impact factor: 5.226

8.  The initiator titration model: computer simulation of chromosome and minichromosome control.

Authors:  F G Hansen; B B Christensen; T Atlung
Journal:  Res Microbiol       Date:  1991 Feb-Apr       Impact factor: 3.992

9.  Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults.

Authors:  Punnee Pitisuttithum; Sorachai Nitayaphan; Prasert Thongcharoen; Chirasak Khamboonruang; Jerome Kim; Mark de Souza; Thippawan Chuenchitra; Robin P Garner; Darawan Thapinta; Victoria Polonis; Silvia Ratto-Kim; Penprapa Chanbancherd; Joseph Chiu; Deborah L Birx; Anne-Marie Duliege; John G McNeil; Arthur E Brown
Journal:  J Infect Dis       Date:  2003-07-03       Impact factor: 5.226

10.  Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network.

Authors:  R B Belshe; B S Graham; M C Keefer; G J Gorse; P Wright; R Dolin; T Matthews; K Weinhold; D P Bolognesi; R Sposto
Journal:  JAMA       Date:  1994-08-10       Impact factor: 56.272

View more
  3 in total

1.  Risk.

Authors:  Stephen R Cole; Michael G Hudgens; M Alan Brookhart; Daniel Westreich
Journal:  Am J Epidemiol       Date:  2015-02-05       Impact factor: 4.897

Review 2.  From Epidemiologic Knowledge to Improved Health: A Vision for Translational Epidemiology.

Authors:  Michael Windle; Hojoon D Lee; Sarah T Cherng; Catherine R Lesko; Colleen Hanrahan; John W Jackson; Mara McAdams-DeMarco; Stephan Ehrhardt; Stefan D Baral; Gypsyamber D'Souza; David W Dowdy
Journal:  Am J Epidemiol       Date:  2019-12-31       Impact factor: 4.897

3.  Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa.

Authors:  Jacob Bor; Matthew P Fox; Sydney Rosen; Atheendar Venkataramani; Frank Tanser; Deenan Pillay; Till Bärnighausen
Journal:  PLoS Med       Date:  2017-11-28       Impact factor: 11.613

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.